Amphastar Pharmaceuticals (AMPH) EPS (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) EPS from Jun 30, 2013 to Mar 31, 2026. The TTM Amphastar Pharmaceuticals (AMPH) EPS is $1.72. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Amphastar Pharmaceuticals (AMPH) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -41.44% |
| 3 Years TTM | -3.68% |
| 5 Years TTM | +101.29% |
| 10 Years TTM | +69.65% |
Annual EPS change of Amphastar Pharmaceuticals (AMPH)
| Year | EPS | Change |
|---|---|---|
| 2026 | $0.14 | -93.31% |
| 2025 | $2.15 | -35.85% |
| 2024 | $3.35 | +17.08% |
| 2023 | $2.86 | +50.63% |
| 2022 | $1.90 | +45.90% |
| 2021 | $1.30 | +4316.73% |
| 2020 | $0.03 | -97.19% |
| 2019 | $1.05 | -953.60% |
| 2018 | -$0.12 | -257.23% |
| 2017 | $0.08 | -63.13% |
| 2016 | $0.21 | -443.98% |
| 2015 | -$0.06 | -74.24% |
| 2014 | -$0.24 | -178.34% |
| 2013 | $0.31 | -34.75% |
| 2012 | $0.47 | N/A |
Comparison Amphastar Pharmaceuticals (AMPH) five years EPS CAGR with competitors
Amphastar Pharmaceuticals (AMPH) five years EPS CAGR is 101.37%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| CPIX | Cumberland Pharmaceuticals Inc | 28.58% | -71.80% |
| RGC | Regencell Bioscience Holdings Ltd | 27.66% | -72.71% |
| UTHR | United Therapeutics Corp | 26.56% | -73.80% |
| ANIP | ANI Pharmaceuticals Inc | 25.74% | -74.61% |
| LFCR | Lifecore Biomedical Inc | 16.09% | -84.13% |
| PAHC | Phibro Animal Health Corp - Class A | 15.27% | -84.93% |
| ZTS | Zoetis Inc - Class A | 10.56% | -89.58% |
| NBIX | Neurocrine Biosciences Inc | 9.25% | -90.87% |
| PBH | Prestige Consumer Healthcare Inc | 8.18% | -91.93% |
| BCRX | Biocryst Pharmaceuticals Inc | 6.24% | -93.84% |
| BHC | Bausch Health Companies Inc | 2.51% | -97.52% |
| RDY | Dr. Reddy`s Laboratories Ltd | 2.45% | -97.59% |
| YCBD | cbdMD Inc | 1.50% | -98.52% |